Anupam Rasayan India
Market cap ₹15,041 Cr
- P/E
- 72.31
- Day range
- ₹1,310.10 – ₹1,327.00
- 52-week range
- ₹1,067.80 – ₹1,415.00
- Volume
- 4.04 L
- Open
- ₹1,320.00
- Prev close
- ₹1,317.50
Latest results · Q2 FY27(consolidated)Revenue ₹806 Cr+10.2%Profit ₹65 Cr+13.7%Margin 8.1%YoY vs the same quarter last year
1 red flag to read up on
- high
Promoter pledge went up
32.85% of promoter shares pledged, up from 21.79% · 30 Sept 2026
From NSE and BSE filings. A flag is a reason to read the filing, not a rating.
ANURAS in NSE indices and F&O
Research profile
Composite 57 / 100Factor percentiles
Derived metrics
- Earn. yield
- 1.4%
- Graham no.
- ₹400.49
- vs Graham
- -69.7%
- ROE ÷ P/B
- 2.5%
- 12-1 mom.
- +8.8%
- Return / vol
- 0.82
- Magic Formula
- #585
- Piotroski
- 3/6
- FCF yield
- -1.5%
Appears in 13 scans
Percentiles rank this stock against the other tracked stocks and change as they do. Scans describe where figures sit today. Hover a label for its definition. Not investment advice.
Peer comparison
All 44 in Chemicals| Company | M-cap | P/E | P/B | ROE | ROCE | OPM | D/E | Sales YoY |
|---|---|---|---|---|---|---|---|---|
| Solar IndustriesSOLARINDS | ₹1.68 L Cr | 74.04 | 22.19 | 32.5% | 38.0% | 29.0% | 0.23 | +69.0% |
| Pidilite IndustriesPIDILITIND | ₹1.56 L Cr | 58.12 | 14.05 | 24.0% | 31.0% | 20.0% | 0.03 | +20.9% |
| SRF LtdSRF | ₹72,471 Cr | 31.75 | 4.80 | 13.8% | 15.0% | 19.0% | 0.35 | +34.7% |
| Linde IndiaLINDEINDIA | ₹58,548 Cr | 118.46 | 13.42 | 13.6% | 18.0% | 32.0% | 0.23 | +12.3% |
| Coromandel InternationalCOROMANDEL | ₹57,701 Cr | 37.01 | 4.30 | 16.1% | 22.0% | 9.0% | 0.12 | +6.6% |
| Gujarat FluorochemicalsFLUOROCHEM | ₹52,952 Cr | 78.39 | 6.17 | 7.6% | 10.0% | 27.0% | 0.28 | +45.5% |
| Navin Fluorine InternationalNAVINFLUOR | ₹52,759 Cr | 57.95 | 11.37 | 20.1% | 21.0% | 34.0% | 0.28 | +57.1% |
| Anupam Rasayan IndiaANURAS | ₹15,041 Cr | 72.31 | 2.94 | 7.2% | 7.0% | 23.0% | 0.50 | +10.3% |
| Sector median | ₹13,505 Cr | 31.75 | 2.86 | 9.9% | 12.0% | 15.7% | 0.27 | +21.5% |
Sector as classified in the tracked universe; medians use every tracked Chemicals company, and P/E only profitable ones. Tinted figures beat the median.
Latest news
Updated 6h agoHeadlines about Anupam Rasayan India from the last two weeks in the financial press. Stories belong to their publishers; Rajat Finance does not endorse them.
Key metrics
- P/E (TTM)
- 83.4
- Price / Book
- 2.98
- ROE (FY26)
- 7.2%
- ROCE (latest year)
- 7%
- Dividend yield
- 0.11%
Moving averages (NSE)
- 20-day
- ₹1,181.66
- Price above
- 50-day
- ₹1,181.36
- Price above
- 200-day
- ₹1,253.68
- Price above
Charts & trends
From company filings. Amounts in ₹ crore.
Revenue, profit & margin - quarterly
₹ crore; a loss shows red. Operating margin below, same periods.
- Revenue
- Net profit
Operating margin
Who owns the company
% of equity by quarter, latest Sept 2026
- Promoter
- Public
- FII
- DII
Cash flows
Where cash came from and went, by fiscal year (₹ crore)
- Operating
- Investing
- Financing
- Free cash flow
Return on equity
Net profit over shareholders' equity, by fiscal year
Equity vs debt
Shareholders' equity against borrowings (₹ crore); the ratio below, same years.
- Equity
- Debt
Debt to equity
Dividends per share
₹ by fiscal year of the ex-date; the latest year runs to date.
Financial statements
| Line item | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 296 | 401 | 254 | 294 | 390 | 500 | 486 | 731 | 512 | 636 | 655 | 806 |
| YoY Sales growth | -25 | -16 | -34 | -25 | — | — | — | — | — | — | — | — |
| Expenses | 216 | 308 | 201 | 214 | 266 | 356 | 362 | 596 | 385 | 498 | 493 | 619 |
| Operating Profit | 79 | 93 | 53 | 80 | 124 | 144 | 124 | 136 | 127 | 137 | 162 | 187 |
| OPM % | 27% | 23% | 21% | 27% | 32% | 29% | 26% | 19% | 25% | 22% | 25% | 23% |
| Other Income | 2 | 12 | 6 | 2 | -4 | 6 | 5 | 8 | 2 | 3 | 13 | 15 |
| Interest | 25 | 26 | 22 | 27 | 32 | 31 | 36 | 36 | 35 | 42 | 49 | 56 |
| Depreciation | 20 | 21 | 21 | 22 | 29 | 31 | 31 | 32 | 34 | 43 | 56 | 57 |
| Profit before tax | 36 | 58 | 16 | 34 | 59 | 88 | 63 | 76 | 60 | 56 | 70 | 89 |
| Tax % | 28% | 30% | 25% | 10% | 9% | 29% | 23% | 24% | -1% | 0% | 27% | 27% |
| Net Profit | 26 | 40 | 12 | 31 | 54 | 63 | 48 | 57 | 61 | 56 | 51 | 65 |
| EPS in Rs | ₹1.68 | ₹2.82 | ₹0.36 | ₹1.52 | ₹2.56 | ₹4.05 | ₹3.10 | ₹3.90 | ₹4.31 | ₹3.75 | ₹3.39 | ₹4.39 |
From company filings, updated 19 Nov 2026. Consolidated figures where the company reports them. Information only, not investment advice.
Working-capital cycle
+56 days since Mar 2021
-40 days since Mar 2021
+46 days since Mar 2021
-31 days since Mar 2021
-60 days since Mar 2021
Strengths, risks & growth
Anupam Rasayan India Ltd is engaged in manufacturing of specialty chemicals, which are sold in local as well as exported to other countries. [1]
Strengths
None flagged by the checklist.
Risks
- Stock is trading at 2.98 times its book value
- Company has a low return on equity of 4.62% over last 3 years.
- Promoters have pledged 32.8% of their holding.
- Dividend payout has been low at 9.85% of profits over last 3 years
Compounded Sales Growth
- 10 Years
- —
- 5 Years
- +24%
- 3 Years
- +14%
- TTM
- +24%
Compounded Profit Growth
- 10 Years
- —
- 5 Years
- +19%
- 3 Years
- -2%
- TTM
- +19%
Stock Price CAGR
- 10 Years
- —
- 5 Years
- +10%
- 3 Years
- +12%
- 1 Year
- +18%
Return on Equity
- 10 Years
- —
- 5 Years
- +6%
- 3 Years
- +5%
- Last Year
- +6%
Strengths and risks are a machine-generated checklist, not advice; growth is compounded annually over each period.
Shareholding pattern
| Holder | Dec 2025 | Mar 2026 | Jun 2026 | Sept 2026 | Change |
|---|---|---|---|---|---|
| Promoter | 59.07% | 59.07% | 59.07% | 59.07% | 0.00 pp |
| FII | 7.60% | 6.91% | 7.72% | 8.65% | +0.93 pp |
| DII | 0.41% | 0.35% | 0.38% | 2.26% | +1.88 pp |
| Public | 32.89% | 33.65% | 32.82% | 30.00% | -2.82 pp |
Filed with NSE for Sept 2026: promoters 59.07%, public 40.93%
Analysts & fund holdings
Who holds the shares, quarter by quarter
Mutual funds 0.43% (+0.24 pp)- Promoters59.1%
- Foreign institutions8.7%
- Mutual funds0.4%
- Insurance0.0%
- Other domestic institutions1.8%
- Retail2.9%
- Others27.1%
| Fund | % of company | % of fund | 3-month change |
|---|---|---|---|
| ITI Mid Cap Fund | 0.15% | 1.60% | +1.60 pp |
| Nippon India Nifty Smallcap 250 Index Fund | 0.04% | 0.16% | -0.01 pp |
| ITI ELSS Tax Saver Fund | 0.04% | 1.30% | +1.30 pp |
| SBI Nifty Smallcap 250 Index Fund | 0.02% | 0.16% | -0.01 pp |
| Motilal Oswal Nifty Smallcap 250 Index Fund | 0.01% | 0.16% | -0.01 pp |
Scorecard
- Performance
- Avg
- Valuation
- High
- Growth
- Low
- Profitability
- High
- Entry point
- Bad
- Red flags
- Avg
Analyst coverage, holdings and scorecard from market data; not a recommendation by Rajat Finance.
Risk & trend
From 292 daily sessions to 18 Nov 2026.
Risk
- Volatility (1Y)
- 27.2%
- Downside volatility
- 28.0%
- Worst 5% of days
- 2.7%
- Average of that tail
- 4.4%
- Max drawdown (1Y)
- 20.2%
- Below its peak
- 4.0%
Against the market
- Beta vs Nifty 50
- 0.39
- Correlation
- 0.19
- Relative strength (3M)
- +6.5%
- ATR (14)
- 2.6%
Return
- Return 1M
- +12.3%
- Return 3M
- +10.4%
- Return 6M
- -2.9%
- Return 1Y
- +22.2%
- vs 200-day average
- +5.4%
Momentum
- RSI (14) · overbought
- 74.5
- MACD histogram
- 21.63
- Stochastic %K
- 95.4
- ADX (14)
- 34.4
- +DI / −DI
- 35.8 / 10.0
- Money flow index
- 88.2
Participation
- Delivery (20d avg)
- 59.9%
- vs its 60-day baseline
- -0.4 pts
- Volume vs 20-day
- -0.4σ
- Close vs day's VWAP
- +0.2%
- 52-week position
- 82 / 100
These describe what this stock's price has already done. They are not forecasts, signals or recommendations, and a dash means the figure was withheld for want of enough history rather than being zero.
Financial quality
From consolidated statements to 30 Sept 2026.
Piotroski F-Score
3 of 6 tested
- Return on assets positive — passed
- Operating cash flow positive — not testableno cash flow statement for this period
- Return on assets improving — failed
- Cash flow exceeds profit — not testableneeds cash flow and profit against assets
- Debt to assets falling — passed
- Current ratio improving — passed
- No new equity issued — not testableno share count is collected, and financing cash flow mixes equity with debt
- Operating margin improving — failed
- Asset turnover improving — failed
- Free cash flow
- -₹221 Cr
- FCF yield
- -1.5%
- Cash conversion
- 1.50
- Accruals ratio
- -0.014
- Net debt
- ₹1,900 Cr
- Net debt / equity
- 0.38
- EV / sales
- 6.49
- Capex intensity
- 23.5%
- Revenue CAGR
- 37.4%
- Profit CAGR
- 2.1%
Computed from filed statements, not filed themselves. A dash means an input was absent, and the score counts only the criteria that could actually be tested.
Corporate actions
- dividend₹1.50
Dividend - Rs 1.50 Per Share
18 Sept 2026ex-date - dividend₹0.75
Interim Dividend - Rs 0.75 Per Sh
21 Jul 2025ex-date - dividendNot available — not reported in this filing
Dividend - Re 0.75 Per Share
17 Sept 2024ex-date - dividendNot available — not reported in this filing
Interim Dividend - Re 0.50 Per Share
20 Nov 2023ex-date - otherNot available — not reported in this filing
Annual General Meeting
22 Sept 2023ex-date - dividend₹1.50
Interim Dividend - Rs 1.50 Per Share
15 May 2023ex-date - dividendNot available — not reported in this filing
Interim Dividend - Re 0.60 Per Share
8 Feb 2023ex-date - dividendNot available — not reported in this filing
Dividend - Re 1 Per Share
2 Sept 2022ex-date - otherNot available — not reported in this filing
Annual General Meeting
2 Sept 2022ex-date - dividend₹0.40
Interim Dividend - Rs 0.40 Per Share
3 Aug 2022ex-date - dividend₹0.50
Interim Dividend - Rs 0.50 Per Share
17 Nov 2021ex-date - dividend₹0.50
Dividend - Rs 0.50 Per Share
15 Sept 2021ex-date - otherNot available — not reported in this filing
Annual General Meeting
15 Sept 2021ex-date
Company announcements
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Catalyst Trusteeship Ltd
Confirmation of Non-Applicability of Regulation 74(5) of SEBI DP Regulations, for the quarter ended September 30, 2026.
The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on October ....
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on October 06, 2026 for Mona Anandbhai Desai
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Catalyst Trusteeship Ltd
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on October 03, 2026 for Rehash Industrial ....
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on October 03, 2026 for Mona Anandbhai Desai
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on October 01, 2026 for Anand Sureshbhai ....
Submission of Scrutinizer's Report along with e-voting results of 23rd Annual General Meeting held on September 30, 2026.
Update on disclosure dated 28 September 2026 on the intimation of acquisition of equity shares of Bliss GVS Pharma Limited.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on September 30, 2026 for Anand Sureshbhai Desai
Submission of proceedings of the 23rd Annual General Meeting of members of the Company held on September 30, 2026.
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Catalyst Trusteeship Ltd
Acquisition of equity shares of Bliss GVS Pharma Limited.
The trading window of the Company for dealing in the securities shall remain closed from Thursday, 01 October 2026 till the end of the 48 hours after declaration of unaudited Financial ....
Filed with BSE (scrip 543275); the last 45 days. Documents open at bseindia.com.
Documents
Annual reports
Earnings calls
- Nov 2026TranscriptSlidesRecording
- Aug 2026TranscriptSlidesRecording
- May 2026TranscriptSlidesRecording
- May 2026Slides
- Feb 2026TranscriptSlides
- Dec 2025TranscriptSlidesRecording
Credit ratings
- Rating update · 31 Aug from crisil
- Rating update · 24 Aug from crisil
- Rating update · 3 Jun from fitch
- Rating update · 2 Jun from crisil
- Rating update · 18 Mar from crisil
- Rating update · 18 Dec 2025 from crisil
Documents open at BSE or the rating agency that issued them.
Sourced from the company's NSE XBRL filing dated 7 Nov 2026 (unaudited). View the source filing. Figures are as filed and are not investment advice.
Anupam Rasayan India: common questions
Answered from the figures on this page.